Plasma leptin levels and triglyceride secretion rates in VMH-lesioned obese rats: A role of adiposity

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 4 39-4, 1999, Pages

  Suga, Asako ^a,b   Hirano, Tsutomu ^a   Inoue, Shuji ^b   Tsuji, Masatomi ^a   Osaka, Toshimasa ^b   Namba, Yoshio ^b   Miura, Masakazu ^c   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Hyperinsulinemia; Insulin resistance; Ventromedial hypothalamus lesions

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN INJURY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; STEADY STATE; WEIGHT GAIN; ZONA INCERTA;

EID: 0032899776     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.4.e650     Document Type: Article

References (41)

1. Abbott, W. G., S. Lillioja, A. A. Young, J. K. Zawadzki, H. Yki-Jarvinen, L. Christin, and B. V. Howard. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 36: 897-904, 1987.
2. Bagdade, J. D., E. L. Bierman, and D. Porte, Jr. Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia. Diabetes 20: 664-672, 1971.
3. Barr, V. A., D. Malide, M. J. Zarnowski, S. I. Taylor, and S. W. Cushman. Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology 138: 4463-4472, 1997.
4. Bray, G. A., and D. A. York. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol. Rev. 59: 719-809, 1979.
5. Byrne, C. D., N. P. Brindle, T. W. Wang, and C. N. Hales. Interaction of non-esterifled fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem. J. 280: 99-104, 1991.
6. Byrne, C. D., T. W. Wang, and C. N. Hales. Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin. Biochem. J. 288: 101-107, 1992.
7. Campbell, P. J., and M. G. Carlson. Impact of obesity on insulin action in NIDDM. Diabetes 42: 405-410, 1993.
8. Caro, J. F., M. K. Sinha, J. W. Kolaczynski, P. L. Zhang, and R. V. Considine. Leptin: the tale of an obesity gene. Diabetes 45: 1455-1462, 1996.
9. Castelli, W. P. Epidemiology of coronary heart disease: the Framingham study. Am. J. Med. 76: 4-12, 1984.
10. Coppack, S. W., R. D. Evans, R. M. Fisher, K. N. Frayn, G. F. Gibbons, S. M. Humphreys, M. L. Kirk, J. L. Potts, and T. D. Hockaday. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41: 264-272, 1992.
11. Cummings, M. H., G. F. Watts, A. M. Umpleby, T. R. Hennessy, J. M. Kelly, N. C. Jackson, and P. H. Sonksen. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 44: 1059-1065, 1995.
12. Dixon, J. L., S. Furukawa, and H. N. Ginsberg. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266: 5080-5086, 1991.
13. Dua, A., M. I. Hennes, R. G. Hoffmann, D. L. Maas, G. R. Krakower, G. E. Sonnenberg, and A. H. Kissebah. Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 45: 1635-1637, 1996.
14. Durrington, P. N., R. S. Newton, D. B. Weinstein, and D. Steinberg. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J. Clin. Invest. 70: 63-73, 1982.
15. Egusa, G., W. F. Beltz, S. M. Grundy, and B. V. Howard. Influence of obesity on the metabolism of apolipoprotein B in humans. J. Clin. Invest. 76: 596-603, 1985.
16. Frederich, R. C., B. Lollmann, A. Hamann, A. Napolitano-Rosen, B. B. Kahn, B. B. Lowell, and J. S. Flier. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 96: 1658-1663, 1995.
17. Harano, Y., S. Ohgaku, H. Hidaka, K. Haneda, R. Kikkawa, Y. Shigeta, and H. Abe. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J. Clin. Endocrinol. Metab. 45: 1124-1127, 1977.
18. Hirano, T., J. C. Mamo, and T. Takahashi. Comparison of the isotopical tracer and the Triton WR 1339 methods for triglyceride kinetics in carbohydrate-fed rats. J. Nutr. Sci. Vitaminol. (Tokyo) 36: 399-409, 1990.
19. Inoue, S., S. Satoh, K. Tanaka, Y. Takamura, and T. Murase. Determinants of fasting hypertriglyceridemia in ventromedial hypothalamic obesity in rats. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R786-R791, 1993.
20. Jacob, R. J., J. Dziura, M. B. Medwick, P. Leone, S. Caprio, M. During, G. I. Shulman, and R. S. Sherwin. The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes 46: 150-152, 1997.
21. Kazumi, T., T. Hirano, H. Odaka, T. Ebara, N. Amano, T. Hozumi, Y. Ishida, and G. Yoshino. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone. Diabetes 45: 806-811, 1996.
22. Kazumi, T., M. Vranic, and G. Steiner. Triglyceride kinetics: effects of dietary glucose, sucrose, or fructose alone or with hyperinsulinemia. Am. J. Physiol. 250 (Endocrinol. Metab. 13): E325-E330, 1986.
23. Kissebah, A. H., S. Alfarsi, P. W. Adams, and V. Wynn. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 12: 563-571, 1976.
24. Lewis, G. F. Fatty acid regulation of very low density lipoprotein production. Curr. Opin. Lipidol. 8: 146-153, 1997.
25. Lewis, G. F., K. D. Uffelman, L. W. Szeto, and G. Steiner. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 42: 833-842, 1993.
26. Lewis, G. F., K. D. Uffelman, L. W. Szeto, B. Weller, and G. Steiner. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J. Clin. Invest. 95: 158-166, 1995.
27. Lopez-Soriano, J., N. Carbo, F. J. Lopez-Soriano, and J. M. Argiles. Short-term effects of leptin on lipid metabolism in the rat. FEBS Lett. 431: 371-374, 1998.
28. Olefsky, J. M., J. W. Farquhar, and G. M. Reaven. Reappraisal of the role of insulin in hypertriglyceridemia. Am. J. Med. 57: 551-560, 1974.
29. Penicaud, L., C. Larue-Achagiotis, and J. Le Magnen. Endocrine basis for weight gain after fasting or VMH lesion in rats. Am. J. Physiol. 245 (Endocrinol. Metab. 8): E246-E252, 1983.
30. Risser, T. R., G. M. Reaven, and E. P. Reaven. Intestinal very low density lipoprotein secretion in insulin-deficient rats. Diabetes 27: 902-908, 1978.
31. Satoh, N., Y. Ogawa, G. Katsuura, T. Tsuji, H. Masuzaki, J. Hiraoka, T. Okazaki, M. Tamaki, M. Hayase, Y. Yoshimasa, S. Nishi, K. Hosoda, and K. Nakao. Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138: 947-954, 1997.
32. Sparks, J. D., and C. E. Sparks. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J. Biol. Chem. 265: 8854-8862, 1990.
33. Sparks, J. D., and C. E. Sparks. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim. Biophys. Acta 1215: 9-32, 1994.
34. Steiner, G., F. J. Haynes, G. Yoshino, and M. Vranic. Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am. J. Physiol. 246 (Endocrinol. Metab. 9): E187-E192, 1984.
35. Tobey, T. A., M. Greenfield, F. Kraemer, and G. M. Reaven. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165-171, 1981.
36. Wiggins, D., R. Hems, and G. F. Gibbons. Decreased sensitivity to the inhibitory effect of insulin on the secretion of very-low-density lipoprotein in cultured hepatocytes from fructose-fed rats. Metabolism 44: 841-847, 1995.
37. Wright, D. W., R. I. Hansen, C. E. Mondon, and G. M. Reaven. Sucrose-induced insulin resistance in the rat: modulation by exercise and diet. Am. J. Clin. Nutr. 38: 879-883, 1983.
38. Yoshino, G., T. Hirano, E. Maeda, Y. Murata, Y. Naka, K. Nagata, T. Kazumi, and T. Urayama. Effect of long-term exogenous hyperinsulinemia and fructose or glucose supplementation on triglyceride turnover in rats. Atherosclerosis 129: 33-39, 1997.
39. Yoshino, G., T. Hirano, K. Nagata, E. Maeda, Y. Naka, Y. Murata, T. Kazumi, and M. Kasuga. Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglyceride: overproduction of triglyceride-rich lipoprotein is not an obligatory factor. J. Lipid Res. 34: 875-884, 1993.
40. Zavaroni, I., S. Sander, S. Scott, and G. M. Reaven. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 29: 970-973, 1980.
41. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.